SB 533: Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs.

Public testimony analysis — 58 testimonies submitted

Testimony Sentiment

53.4%
43.1%

31

Support

25

Oppose

2

Neutral

Organizational Positions20 organizations

Individual Testimony by Location27 locations

LocationTotalSupportOppose
Salem514
PhRMA202
Tigard220
875 Oak Street SE Suite 4030 Salem OR 97301101
Albertsons Companies110
Alexandria VA100
Astoria110
AstraZeneca101
BIO101
Bridge-Pamoja101
Cascade AIDS Project110
Central City Concern110
EUGENE101
Eli Lilly and Company101
Enterprise OR110
GSK101
Genentech101
Hermiston Astoria Clatskanie Newberg McMinnville110
Hillsboro110
Hood River and The Dalles110
Kaleidoscope Fighting Lupus101
Northwest Human Services110
OHSU110
Ontario110
Portland110